Compound: Ruxolitinib

Drug Target: JAK1, JAK2

Drug Target pathway: Other, kinases

Dataset


Tissue specific analysis

Ruxolitinib IC50 values for cnaPANCAN139

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.